Navigation Links
HealthEdge Receives $13 Million Investment Commitment to Fund Significant Growth
Date:4/22/2008

HealthEdge's Revolutionary Software Platform-HealthRules(R)-Poised to

Change the Rules for Healthcare Payors

BURLINGTON, Mass., April 22 /PRNewswire/ -- HealthEdge, the leading provider of next-generation claims and benefit administration, business intelligence and portal software products for healthcare payors, today announced that it has secured a $13 million investment commitment from Psilos Group, a leading healthcare venture capital and private equity firm.

"We believe that HealthEdge's HealthRules is the only software platform that meets the needs of today's healthcare marketplace," said Dr. Albert Waxman, senior managing member of Psilos Group. "The legacy systems currently in use at most health plans cannot respond to the evolving consumer-focused healthcare economy which demands support for personalized benefits and complex financial transaction management. HealthEdge is uniquely positioned to provide payor organizations of all sizes the ability to quickly offer the kinds of innovative products that the market demands and to make long overdue reductions in administrative overhead. Psilos is excited to extend our support of HealthEdge as it continues to expand its products and services."

"We are seeing unprecedented demand for our products," remarked Rob Gillette, CEO of HealthEdge. "The healthcare payor community has now realized that a contemporary software platform, built with the next generation of healthcare in mind, is no longer a luxury, but a necessity. We are extremely pleased to have Psilos Group as our investment partner."

HealthEdge will use the funds to increase the size of its business and to continue to invest in advanced product capabilities.

About HealthEdge

HealthEdge provides health plans, TPAs, PPOs and insurers of all sizes unique software products that enable them to compete in the new healthcare market. Payor organizations are able to pursue innovative, new strategies focused on increasing revenue, decreasing costs and improving the quality of healthcare. HealthEdge provides HealthRules(R), a next-generation, patented software platform for core administrative processes, business intelligence, and web self-service. The company is headquartered in Burlington, Massachusetts.

About Psilos Group

Psilos Group has been a successful healthcare venture capital and private equity firm since its founding in 1998. With over $500MM under management, Psilos focuses its investments across the healthcare services, healthcare information technology, and medical technology sectors. Psilos invests nationwide in businesses that are poised to create enduring market value by fundamentally improving the U.S. healthcare system. Our portfolio companies are sustainable and high-value businesses that have a demonstrated ability to reduce the costs of healthcare delivery, improve clinical quality and advance the alignment of payer, patient and provider incentives. Psilos has offices in New York, the San Francisco Bay Area and Santa Fe, New Mexico.

For more information, contact:

Maria Malavenda

SVP, Marketing

HealthEdge

781-419-6134

mmalavenda@healthedge.com


'/>"/>
SOURCE HealthEdge
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Seattle-Based Law Firm Williams Kastner Receives Significant Defense Verdict in Trade Secret Business Litigation Case
2. Arkion(R) Life Sciences Receives Crisis Exemption to US EPA Section 18 Approval in Mississippi and Tennessee to Market Avitec Corn Seed Treatment
3. QMed, Inc. Receives NASDAQ Delisting Letter
4. Ezra Susser, MD, DrPH, receives Distinguished Investigator Award from NARSAD
5. Compensation Risk Managers, LLC Receives Notice of Administrative Action by New York Workers Compensation Board
6. Tasker Products Receives USDA Consent to Begin Immediate Commercialization of Tasker Clear Throughout Entire Poultry Processing Operations
7. Draeger Receives Frost & Sullivan Consumer Award for Respiratory Protection
8. Easter Seals Receives $1 Million Donation From CVS Caremark Charitable Trust to Enhance Autism Services for Children
9. African medical research and training receives Wellcome boost
10. Sen. Robert Byrd Receives AOA Health Care Leadership Award
11. Reproductive Science Center of New England Receives Ambulatory Health Care Accreditation
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/8/2016)... ... February 08, 2016 , ... Stephanie Hebert Insurance ... beginning of a new charity campaign. As part of their ongoing community involvement ... In the belief that children deserve a voice, and in the spirit of ...
(Date:2/8/2016)... ... February 08, 2016 , ... Tingley ... into Canada to provide its range of unique and advantaged protective solutions ... City that will provide bilingual customer service and marketing support. A new distribution ...
(Date:2/8/2016)... ... February 08, 2016 , ... ... announced today that nominations will be accepted February 8, 2016 through May ... , Awards include the Information Security Executive® of the Year, which recognizes ...
(Date:2/8/2016)... ... February 08, 2016 , ... ... lower incidence rate of type 2 diabetes in the GrassrootsHealth cohort with substantially ... to make a change in public health,” states Carole Baggerly, Director of GrassrootsHealth, ...
(Date:2/8/2016)... ... February 08, 2016 , ... The schedule is now online ... AutismOne 2016 Conference, which is being held May 25-29 at the Loews Chicago O’Hare ... helpful interventions and causes of chronic illness in children. , Very recent articles have ...
Breaking Medicine News(10 mins):
(Date:2/9/2016)... 2016  The Parenteral Drug Association, Inc. (PDA), ... manufacturing sterile drug products, today announced the publication ... – With link to Comparison Spreadsheet. The ... U.S. FDA, the EU, the Pharmaceutical Inspection Convention/Scheme ... --> --> PDA,s Global Sterile ...
(Date:2/8/2016)... Feb.8, 2016 Cardiovascular Surgery Devices - ... GlobalData,s Medical Devices sector report, "Cardiovascular Surgery Devices ... overview of Cardiovascular Surgery Devices currently in pipeline ... The report provides comprehensive information on the ... at various stages of development. The report reviews ...
(Date:2/8/2016)... FAIRFIELD, N.J. , Feb. 8, 2016  Otsuka ... today announced that they have entered into a licensing ... OPA-15406 in the U.S. and Puerto Rico ... is a topical, non-steroidal phosphodiesterase IV (PDE-4) inhibitor, a ... --> --> In a Phase II ...
Breaking Medicine Technology: